Nepal bans import of medicines from 16 Indian firms 

Nepal’s Division of Drug Administration has banned the import of medicines from 16 Indian pharmaceutical corporations.

Nepal has banned import of medicines from 16 Indian companies. (Picture for Illustration/ Reuters)

By Milan Sharma: Nepal has banned the import of medicines from 16 Indian corporations for failing to adjust to the World Well being Group’s (WHO) good manufacturing practices. The transfer comes following an alert by the WHO over Indian-made cough syrups allegedly linked to the demise of kids in Gambia.

The 16 Indian pharmaceutical companies on Nepal’s banned listing embody Divya Pharmacy that manufactures Yoga guru Ramdev’s Patanjali merchandise.

The listing by Nepal’s Division of Drug Administration consists of Radiant Parenterals Ltd., Mercury Laboratories Ltd., Alliance Biotech, Captab Biotec, Aglowmed Restricted, Zee Laboratories Ltd, Daffodils Prescription drugs Ltd,GLS pharma Restricted, Unijules Life Science Ltd, Idea Prescription drugs Pvt and many others.

Massive Indian pharma corporations like Shree Anand Life Sciences Ltd, IPCA laboratories Ltd, Cadila Healthcare Ltd, Dial Prescription drugs, Aglowmed Restricted and Mackur laboratories Ltd additionally function on the listing issued by the Nepal drug regulatory authority.

ALERT OVER INDIA-MADE COUGH SYRUPS

The WHO in October issued a medical product alert for 4 contaminated medicines recognized in Gambia that had been linked with acute kidney accidents and 70 deaths amongst kids. The spike in instances of acute kidney harm amongst kids underneath the age of 5 was detected in late July. As instances mounted, medical doctors started to suspect medicines may very well be concerned, Reuters reported.

In response to WHO, the 4 medicines are cough and chilly syrups produced by Maiden Prescription drugs Restricted in India. Following the alert, the Central Medicine Commonplace Management Organisation launched a probe. The Haryana state drug officers later discovered evident lapses throughout the inspection of the manufacturing facility of Maiden Pharma, the agency whose cough syrup was linked to the Gambian youngsters’ deaths.

ALSO READ | No direct hyperlink between Gambia little one deaths, Indian cough syrups: Drug regulator snubs WHO’s alert